The Clinical Guide to Supportive and Palliative Care for HIV/AIDS

A Clinical Guide to Supportive and Palliative Care for HIV/AIDS • Chapter 23: Medical Care in Advanced AIDS23. Wright MT. The old problem of adherence: research on treatment adherence and its relevance for HIV/AIDS.AIDS Care 12:703–10, 2000.24. Stephenson J. AIDS researchers target poor adherence. JAMA 281:1069, 1999.25. Sherr 26 L. Adherence—sticking picas to the evidence. AIDS Care 12:373–5, 2000.26. Laws MB, et al. Taking antiretroviral therapy for HIV infection: learning from patients’ stories.J Gen Intern Med 15:848–58, 2000.27. Kemppainen JK, et al. HAART adherence in culturally diverse patients with HIV/AIDS: a study of male patientsfrom a Veterans Administration Hospital in northern California. AIDS Patient Care STDS 15:117–27, 2001.28. Laurence J. Adhering to antiretroviral therapies. AIDS Patient Care STDS 15:107–8, 2001.29. Katzenstein DA, et al. HIV therapeutics: confronting adherence. J Assoc Nurses AIDS Care 8 Suppl:46–58, 1997.30. Wolfe GS. The case manager’s role in adherence. J Assoc Nurses AIDS Care 8 Suppl:24–8, 1997.31. Baronzio G, et al. Proinflammatory and regulatory cytokine levels in AIDS cachexia in vivo. 13:499–502, 1999.32. Flynn NM, et al. Megestrol for AIDS-related anorexia—Response. Ann Intern Med 122:881, 1995.33. Vonroenn JH, et al. Megestrol acetate in patients with AIDS-related cachexia. Ann Intern Med 121:393–9,1994.34. Gillick MR. Rethinking the role of tube feeding in patients with advanced dementia. N Engl J Med 342:206–10,2000.35. Little RF, Y.R., Wilson WH, Systemic chemotherapy for HIV-associated lymphoma in the era of highly activeantiretroviral therapy. Curr Opin Oncol 12:438-44, 2000.36. Greenlee JE. Progressive multifocal leukoencephalopathy. Progress made and lessons relearned. N Engl J Med338:1378–80, 1998.37. Hall CD, et al. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with humanimmunodeficiency virus. N Engl J Med 338:1345–51, 1998.38. Kamath PS, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 33:464–70,2001.39. Meyers FJ. Letter to the editor. N Engl J Med 340:860-1, 2002.40. Faber-Langendoen K, et al. Dying patients in the intensive care unit: Forgoing treatment, maintaining care.Ann Intern Med 133:886–93, 2000.41. Danis M, et al. Incorporating palliative care into critical care education: Principles, challenges, and opportunities.Crit Care Med 27:2005–13, 1999.42. Benfield TL, et al. Prognostic markers of short-term mortality in AIDS-associated Pneumocystis cariniipneumonia. Chest 119:844–51, 2001.43. Forrest DM, et al. The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviraldrugs. Clin Infect Dis 27:1379–85, 1998.44. Forrest DM, et al. Validation of the modified multisystem organ failure score as a predictor of mortality in patientswith AIDS-related Pneumocystis carinii pneumonia and respiratory failure. Chest 114:199–206, 1998.45. Curtis JR, Patrick DL, Caldwell ES, Collier AC. The attitudes of patients with advanced AIDS toward use of themedical futility rationale in decisions to forgo mechanical ventilation. Arch Intern Med 160:1597–601, 2000.46. Hays RD, et al. Health-related quality of life in patients with human immunodeficiency virus infection in theUnited States: results from the HIV Cost and Services Utilization Study. Am J Med 108:714–22, 2000.47. Back AL, Wallace JI, Starks HE, Pearlman RA. Physician-assisted suicide and euthanasia in Washington state.JAMA 275:919–25, 1996.48. Block SD. Psychological considerations, growth, and transcendence at the end of life. The art of the possible.JAMA 285:2898–905, 2001.XXIIIU.S. Department of Health and Human Services • Health Resources and Services Administration • HIV/AIDS Bureau 491